Q4 2023 Rhythm Pharmaceuticals Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to Rhythm Pharmaceuticals' fourth-quarter and full-year 2023 earnings conference call. (Operator Instructions)
Please be advised that today's conference is being recorded. I would like now to turn the conference over to David Connolly, Investor Relations and Corporate Communications. Please go ahead.
Thank you, Michelle. I'm Dave Connolly here at Rhythm Pharmaceuticals. For those of you participating on the conference [today], our slides can be accessed and controlled by going to the Investors section on the Investors page of our website, ir.rhythmtx.com.
This morning, we issued a press release that provhides our fourth-quarter and year-end 2023 financial results and a business update, which is available on our website. As listed on slide 2 is our agenda.
Here with me today in Boston are David Meeker, Chair, Chief Executive Officer, and President of Rhythm Pharmaceuticals
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |